U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

CDC Updates RSV Vaccination Recommendation for Adults : For the upcoming respiratory virus season, CDC recommends everyone age 75 and older receive the RSV vaccine

Supporting Files Public Domain
File Language:
English


Details

  • Corporate Authors:
    Centers for Disease Control and Prevention (U.S.)
  • Description:
    Media Statement For Immediate Release: Wednesday, June 26, 2024

    Today, CDC updated its recommendation for the use of Respiratory Syncytial Virus (RSV) vaccines in people ages 60 and older. For this upcoming respiratory virus season, CDC recommends:

    • Everyone ages 75 and older receive the RSV vaccine.

    • People ages 60–74 who are at increased risk of severe RSV, meaning they have certain chronic medical conditions, such as lung or heart disease, or they live in nursing homes, receive the RSV vaccine.

    This recommendation is for adults who did not get an RSV vaccine last year. The RSV vaccine is not currently an annual vaccine, meaning people do not need to get a dose every RSV season. Eligible adults can get an RSV vaccine at any time, but the best time to get vaccinated is in late summer and early fall before RSV usually starts to spread in communities.

    Today’s updated recommendation for people 60 and older replaces the recommendation made last year to simplify RSV vaccine decision-making for clinicians and the public.

    Immunizations were available last year for the first time to protect people at increased risk for severe RSV, including infants and young children, and people ages 60 and older. Today’s updated recommendation is based on analyses of RSV disease burden among people 60 and older, as well as RSV vaccine effectiveness and cost-effectiveness studies. Those studies included the first real-world data since RSV vaccines were recommended for people 60 and older.

    Healthcare providers should recommend RSV vaccines to their eligible patients, as well as discuss what other vaccines they will need this fall to help prevent respiratory infections.

  • Subjects:
  • Document Type:
    Press Release
  • Name as Subject:
    ACIP meeting: 2024 June 26-28
  • Genre:
    Media Statement
  • Place as Subject:
    United States
  • Collection(s):
  • Main Document Checksum:
    urn:sha256:4f7891a8d5307f0d6b0b213178e884f9ef36f3040de9cd6f9d3a9db5f1057bdd
  • Download URL:
  • File Type:
    Filetype[PDF - 67.38 KB ]

Supporting Files

PREVIOUS
File Language:
English
ON THIS PAGE
Details Supporting Files
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
BACK TO TOP